Search Results 21-30 of 16764 for pharmacogenetics
ROCHESTER, Minn. – An international group of clinicians and scientists representing the Clinical Pharmacogenetics Implementation Consortium (CPIC) published ...
The Human Genome Project, along with new technologies such as genome-wide association studies, changed the nature of the science from pharmacogenetics to ...
Tamoxifen pharmacogenetics. A current example of Dr. Ames' research involves defining the role of genetic variation in the risk of cancer recurrence in women ...
Researchers in our program study how genetic variants contribute to specific aspects of mental health conditions, including prognosis and response to treatment.
Data used in the study came from a collaboration between Mayo Clinic and the Pharmacogenetics of Methotrexate in Rheumatoid Arthritis (PAMERA) consortium, that ...
ROCHESTER, Minn. — Pharmacogenomics is a valuable tool for health care providers to help prescribe the right drug for the right patient to enhance efficacy ...
New pharmacogenetics program offers local hospital differentiation. Karl E. Bushman, M.D., knows that pharmacogenomics can make a difference. Through Mayo ...
Goetz's focus has been the pharmacogenetics of tamoxifen. Out of this work, and in collaboration with the Developmental Therapeutics Program of the National ...
One part of pharmacogenetic testing looks at the ... The study included 3016 patients who had undergone pharmacogenetics testing between 2003 and 2013.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
There's still time to triple your impact.